Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic hepatitis C--therapeutic modalities for interferon failure]

R Hermann1

  • 1Abteilung für Gastroenterologie, Medizinische Klinik C, Kantonsspital St. Gallen.

Praxis
|November 24, 1998
PubMed
Summary

Alpha-interferon monotherapy for chronic hepatitis C yields poor sustained response rates. This review explores second-line treatment options, including interferon retreatment and combination therapies for non-responders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Rhinology·2026
Same author

Cochlear implantation in the very elderly: Longitudinal assessment of device use and outcomes.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Experimental helium-beam radiography with a high-energy beam: Water-equivalent thickness calibration and first image-quality results.

Medical physics·2022
Same author

Low-fidelity otoscopy simulation and anatomy training: A randomized controlled trial.

European annals of otorhinolaryngology, head and neck diseases·2020
Same author

Evolution and safety of day-case major ear surgery.

European annals of otorhinolaryngology, head and neck diseases·2020
Same author

The French National Cochlear Implant Registry (EPIIC): Cochlear explantation and reimplantation.

European annals of otorhinolaryngology, head and neck diseases·2020

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Chronic hepatitis C (HCV) infection remains a significant global health challenge.
  • Alpha-interferon monotherapy shows limited efficacy, with sustained response rates of only 10-25% in naive patients.
  • The majority of patients either do not respond or relapse after interferon treatment.

Purpose:

  • To review current therapeutic options for second-line treatment in chronic hepatitis C patients.
  • To evaluate the efficacy of interferon retreatment and combination therapies.
  • To guide therapeutic decisions for patients with unsatisfactory responses to initial interferon therapy.

Summary:

  • Interferon monotherapy for chronic hepatitis C is largely unsatisfactory, achieving sustained virologic response in only a minority of patients.
  • Factors predictive of response should be assessed to guide individualized second-line treatment strategies.
  • This review focuses on retreatment with interferon and combination therapies involving ribavirin and amantadine.

Impact:

  • Highlights the limitations of current monotherapy for chronic hepatitis C.
  • Provides a basis for developing personalized treatment algorithms for non-responders.
  • Informs clinical decision-making regarding salvage therapies for chronic hepatitis C.

Related Experiment Videos